[1]
Chaudhari, D.D. and Mevada, H. 2026. Cost-Effectiveness Analysis of Vonoprazan Vs PPIs in the Treatment of Gastroesophageal Reflux Disease. International Journal of Aquatic Research and Environmental Studies. 6, S3 (Jun. 2026), 1161–1167. DOI:https://doi.org/10.70102/mc24f350.